KPTIbenzinga

Karyopharm Therapeutics Earnings Preview

Summary

Karyopharm Therapeutics (NASDAQ:KPTI) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Karyopharm Therapeutics will report an earnings per share (EPS) of $-0.63.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 4, 2022 by benzinga